Discovery predicts patient sensitivity to important drug target in deadly brain cancer
Monday, February 6, 2012 - 16:31
in Health & Medicine
A recent discovery by Van Andel Research Institute (VARI) scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma the most common and most aggressive malignant brain tumor in humans.